UCSF

Tagged: genomics

Phillips discusses insurance coverage for genomic testing

Kathryn Phillips, PhD, discusses insurance coverage for genomic testing in her recent articles published in JAMA and Science.

In a JAMA Viewpoint, April 16, Phillips examines the new CMS coverage policy for genomic tests in cancer patients: “Evolving Payer Coverage Policies on Genomic Sequencing Tests: Beginning of the End or End of the Beginning?

Fischbach joins project to generate drugs from bacterial genomes

Bacteria generate small molecules to fend off their fellow microbes. They also produce molecules that affect the response of host organisms—including humans—to their presence. Such molecules have been a major source of antibiotics, immunosuppressants, anti-cancer agents, and other drugs. But their discovery has not been systematic and the products of bacteria living in our bodies have only recently drawn scientific notice.

Burchard named to expert panel for Obama’s precision medicine plan

School faculty member Esteban G. Burchard, MD, MPH, has been appointed to an expert panel advising the National Institutes of Health (NIH) on how to develop President Barack Obama’s Precision Medicine Initiative.

Nadav Ahituv, PhD

Ahituv
Professor

My research focuses on understanding how nucleotide variation in gene regulatory elements can lead to human disease and other phenotypes. 

Reflection: 30 years of top NIH funding for UCSF School of Pharmacy

Genotyping could lead to stereotyping

While tailoring medications to a group's genetic ancestry can be important, scientists warn that these generalizations might also be misleading. UCSF School of Pharmacy faculty member and pharmacogenetics and asthma researcher Esteban Burchard, MD, comments at the Genomics, Race, and Health Disparities Conference held in Oakland, California on August 18 and 19, 2006.